4-(4-dibenzofuran-2-ylphenyl)-6-(4-dibenzothiophen-3-ylphenyl)-2-(4-pyridin-3-ylphenyl)pyrimidine
C51H31N3OS — CID 130262344
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-(4-dibenzofuran-2-ylphenyl)-6-(4-dibenzothiophen-3-ylphenyl)-2-(4-pyridin-3-ylphenyl)pyrimidine
4-(4-dibenzofuran-2-ylphenyl)-6-(4-dibenzothiophen-3-ylphenyl)-2-(4-pyridin-3-ylphenyl)pyrimidine (PubChem CID 130262344) has the molecular formula C51H31N3OS and a molecular weight of 733.90 g/mol. Its IUPAC name is 4-(4-dibenzofuran-2-ylphenyl)-6-(4-dibenzothiophen-3-ylphenyl)-2-(4-pyridin-3-ylphenyl)pyrimidine.
Molecular Properties
| Compound Name | 4-(4-dibenzofuran-2-ylphenyl)-6-(4-dibenzothiophen-3-ylphenyl)-2-(4-pyridin-3-ylphenyl)pyrimidine |
|---|---|
| PubChem CID | 130262344 |
| Molecular Formula | C51H31N3OS |
| Molecular Weight | 733.90 g/mol |
| Exact Mass | 733.22 |
| IUPAC Name | 4-(4-dibenzofuran-2-ylphenyl)-6-(4-dibenzothiophen-3-ylphenyl)-2-(4-pyridin-3-ylphenyl)pyrimidine |
| SMILES | c1cncc(-c2ccc(-c3nc(-c4ccc(-c5ccc6c(c5)sc5ccccc56)cc4)cc(-c4ccc(-c5ccc6oc7ccccc7c6c5)cc4)n3)cc2)c1 |
| InChI | InChI=1S/C51H31N3OS/c1-3-9-47-41(7-1)44-28-38(24-26-48(44)55-47)32-11-17-35(18-12-32)45-30-46(54-51(53-45)37-21-15-34(16-22-37)40-6-5-27-52-31-40)36-19-13-33(14-20-36)39-23-25-43-42-8-2-4-10-49(42)56-50(43)29-39/h1-31H |
| InChIKey | MRCUQSWZIAFYCE-UHFFFAOYSA-N |
| XLogP | 14.14 |
| TPSA | 51.81 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 56 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 733.90 |
| LogP ≤ 5 | 14.14 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 130262344 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.